Inventor · disambiguated record
Steven P. Govek
Also filed as: GOVEK STEVEN · GOVEK STEVEN P
34 granted patents·25 pending applications·446 citations·filing 2004–2025
97Inventor score
Top patents by PatentIndex Score
59 records- 0197US8853423B2Indane estrogen receptor modulators and uses thereofGOVEK STEVEN P·Filed 2011·Granted Oct 7, 2014·53 cites·11 claims
- 0297US8455534B2Estrogen receptor modulators and uses thereofSMITH NICHOLAS D·Filed 2012·Granted Jun 4, 2013·66 cites·18 claims
- 0397US8299112B2Estrogen receptor modulators and uses thereofSMITH NICHOLAS D·Filed 2011·Granted Oct 30, 2012·72 cites·12 claims
- 0496US9475798B2Azetidine estrogen receptor modulators and uses thereofGENENTECH INC·Filed 2015·Granted Oct 25, 2016·20 cites·14 claims
- 0596US9078871B2Estrogen receptor modulators and uses thereofSERAGON PHARMACEUTICALS INC·Filed 2013·Granted Jul 14, 2015·50 cites·22 claims
- 0696US8703810B2Estrogen receptor modulators and uses thereofKAHRAMAN MEHMET·Filed 2011·Granted Apr 22, 2014·65 cites·21 claims
- 0792US9845291B2Estrogen receptor modulators and uses thereofGENENTECH INC·Filed 2015·Granted Dec 19, 2017·15 cites·14 claims
- 0891US10626081B2Farnesoid X receptor agonists and uses thereofMETACRINE INC·Filed 2016·Granted Apr 21, 2020·4 cites·18 claims
- 0991US9873684B2Estrogen receptor modulators and uses thereofGENENTECH INC·Filed 2015·Granted Jan 23, 2018·11 cites·16 claims
- 1091US9655880B2Azetidine estrogen receptor modulators and uses thereofGENENTECH INC·Filed 2016·Granted May 23, 2017·5 cites·18 claims
- 1191US9193714B2Fluorinated estrogen receptor modulators and uses thereofSERAGON PHARMACEUTICALS INC·Filed 2012·Granted Nov 24, 2015·18 cites·14 claims
- 1289US10377717B2Farnesoid X receptor agonists and uses thereofMETACRINE INC·Filed 2016·Granted Aug 13, 2019·3 cites·18 claims
- 1388US9187460B2Estrogen receptor modulators and uses thereofSERAGON PHARMACEUTICALS INC·Filed 2012·Granted Nov 17, 2015·11 cites·17 claims
- 1487US11773094B2Farnesoid X receptor agonists and uses thereofMETACRINE INC·Filed 2021·Granted Oct 3, 2023·1 cites·19 claims
- 1586US10961198B2Farnesoid X receptor agonists and uses thereofMETACRINE INC·Filed 2018·Granted Mar 30, 2021·2 cites·4 claims
- 1686US7745646B2Bicyclic heteroaryl inhibitors of PDE4KALYPSYS INC·Filed 2007·Granted Jun 29, 2010·7 cites·22 claims
- 1785US2025289821A1Farnesoid x receptor agonists and uses thereofLILLY CO ELI·Filed 2024·Application pending·0 cites
- 1884US11084817B2Farnesoid X receptor agonists and uses thereofMETACRINE INC·Filed 2019·Granted Aug 10, 2021·3 cites·15 claims
- 1983US10703712B2Farnesoid X receptor agonists and uses thereofMETACRINE INC·Filed 2016·Granted Jul 7, 2020·2 cites·16 claims
- 2083US9586952B2Polycyclic estrogen receptor modulators and uses thereofSERAGON PHARMACEUTICALS INC·Filed 2014·Granted Mar 7, 2017·7 cites·37 claims
- 2183US9399646B2Estrogen receptor modulators and uses thereofSMITH NICHOLAS D·Filed 2011·Granted Jul 26, 2016·6 cites·15 claims
- 2282US11236071B1Farnesoid X receptor agonists and uses thereofMETACRINE INC·Filed 2018·Granted Feb 1, 2022·2 cites·18 claims
- 2382US7494999B2Sulfonyl-substituted bicyclic compounds as modulators of PPARKALYPSYS INC·Filed 2005·Granted Feb 24, 2009·6 cites·9 claims
- 2481US8138205B2Heteroarylalkoxy-substituted quinolone inhibitors of PDE4GOVEK STEVEN P·Filed 2009·Granted Mar 20, 2012·4 cites·19 claims
- 2580US2023382913A1Farnesoid x receptor agonists and uses thereofORGANOVO INC·Filed 2023·Application pending·0 cites
- 2678US9499538B2Estrogen receptor modulators and uses thereofSERAGON PHARMACEUTICALS INC·Filed 2013·Granted Nov 22, 2016·4 cites·13 claims
- 2777US10053451B2Heterocyclic estrogen receptor modulators and uses thereofGENENTECH INC·Filed 2016·Granted Aug 21, 2018·2 cites·10 claims
- 2874US8080563B2Bicyclic heteroaryl inhibitors of PDE4GOVEK STEVEN P·Filed 2007·Granted Dec 20, 2011·1 cites·7 claims
- 2974US7960417B2Benzazole potentiators of metabotropic glutamate receptorsMERCK SHARP & DOHME·Filed 2006·Granted Jun 14, 2011·2 cites·15 claims
- 3074US7700591B2Benzoxazinyl-amidocyclopentyl-heterocyclic modulators of chemokine receptorsMERCK & CO INC·Filed 2005·Granted Apr 20, 2010·2 cites·18 claims
- 3171US7834004B2Sulfonyl-substituted bicyclic compounds as modulators of PPARKALYPSYS INC·Filed 2008·Granted Nov 16, 2010·1 cites·37 claims
- 3271US2022081390A1Farnesoid x receptor agonists and uses thereofMETACRINE INC·Filed 2021·Application pending·0 cites
- 3368US8258154B2Bicyclic heteroaryl inhibitors of PDE4GOVEK STEVEN·Filed 2007·Granted Sep 4, 2012·1 cites·13 claims
- 3468US2021300875A1Farnesoid x receptor agonists and uses thereofMETACRINE INC·Filed 2021·Application pending·0 cites
- 3566US11214538B2Farnesoid X receptor agonists and uses thereofMETACRINE INC·Filed 2020·Granted Jan 4, 2022·0 cites·18 claims
- 3666US2022089575A1Farnesoid x receptor agonists and uses thereofMETACRINE INC·Filed 2021·Application pending·0 cites
- 3762US2009227599A1Sulfonyl-substituted bicyclic compounds as modulators of pparKALYPSYS INC·Filed 2009·Application pending·0 cites
- 3861US2024368127A1Hsd17b13 inhibitors and uses thereofFL2022 001 INC·Filed 2022·Application pending·0 cites
- 3960US9868704B2Estrogen receptor modulators and uses thereofGENENTECH INC·Filed 2016·Granted Jan 16, 2018·0 cites·18 claims
- 4058US9078887B2Bicyclic heteroaryl inhibitors of PDE4GOVEK STEVEN P·Filed 2012·Granted Jul 14, 2015·0 cites·17 claims
- 4157US2024083853A1Hsd17b13 inhibitors and uses thereofFL2022 001 INC·Filed 2021·Application pending·0 cites
- 4257US2024034736A1Hsd17b13 inhibitors and uses thereofFL2022 001 INC·Filed 2021·Application pending·0 cites
- 4357US2010105729A1Aryl-substituted heterocyclic pde4 inhibitors as anti-inflammatory agentsKALYPSYS INC·Filed 2007·Application pending·0 cites
- 4457US2024083861A1Hsd17b13 inhibitors and uses thereofFL2022 001 INC·Filed 2021·Application pending·0 cites
- 4557US2009275586A1Heterocyclic inhibitors of pde4KALYPSYS INC·Filed 2007·Application pending·0 cites
- 4655US2025313548A1Heterocyclic compounds useful as kcnt1 inhibitorsACTIO BIOSCIENCES INC·Filed 2025·Application pending·0 cites
- 4754US10227334B2Estrogen receptor modulators and uses thereofGENENTECH INC·Filed 2017·Granted Mar 12, 2019·0 cites·2 claims
- 4854US2022054469A1Farnesoid x receptor agonists and uses thereofMETACRINE INC·Filed 2019·Application pending·0 cites
- 4947US2013045975A1Bicyclic heteroaryl inhibitors of pde4KALYPSYS INC·Filed 2012·Application pending·0 cites
- 5047US2007027321A1Bipyridyl amines and ethers as modulators of metabotropic glutamate receptor-5KAMENECKA THEODORE M·Filed 2004·Application pending·0 cites
Showing the top 50 of 59 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →